HLTHAGE 2F03 Lecture Notes - Lecture 7: Bioequivalence, Breakthrough Therapy, Brand
25 Jan 2018
School
Department
Course
Professor
Document Summary
Brand-name competition: be the first to market a new type of drug and then extend the market power, competition among brand-name manufacturers is seldom about price. Building brand loyalty: build brand loyalty among doctors, direct-to-consumer advertising. Switzerland, the u. l. , and the u. s: the rate of increase in the prices of existing patented drugs cannot exceed the consumer price index, the canadian prices of patented medicines can never be the highest in the world. Drug formulary a list of all the drugs eligible for reimbursement by a drug insurance plan. Each of the provincial drug plans has its own drug formulary: reimbursement at the price of the lowest-cost bio-equivalent drug, reference-based pricing: A policy of reimbursing only the price of the lowest-cost drug intended to treat the condition in question, including drugs that are not bio-equivalent. Over 65 years of age, social assistance, (welfare), high drug costs to. Hospital in-patients (cid:894)(cid:272)overed (cid:271)y hospital (cid:862)glo(cid:271)al(cid:863) (cid:271)udget(cid:895)
